On January 11, 2021 Acorda Therapeutics, Inc. (NASDAQ: ACOR) reported that Ron Cohen, M.D., President and Chief Executive Officer, will present during the January 11th -14th H.C. Wainwright BIOCONNECT Virtual Conference (Press release, Acorda Therapeutics, JAN 11, 2021, View Source [SID1234573818]). An audio webcast of the presentation can be accessed under "Investor Events" in the Investor section of the Acorda website at www.acorda.com.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

For more information about the conference, please visit the event website at www.hcwevents.com/bioconnect.